drugset / Trial / NCT03186547

Satisfaction Of Adult Patients With Gummy Smile Treated By Botulinum Toxin A Injection

NCT03186547

Phase 0 Unknown 22 enrolled Cairo University
RandomizedParallel-groupSingle-blindTreatment

Summary

The aim of the proposal study is to answer the question of how to manage gummy smiles due to hypermobile upper lip with less invasive and low risk level procedure . This trial will help the practitioners and the patients in taking the convenient decision to correct the gumminess to restore lip-gingival-dental harmony and enhance smile asthetics.

Timeline

Start
2017-06
Primary completion
2018-06
Completion
2018-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Botulinum toxin type A Protein / enzyme biologic 2.5 iu
Subject Botulinum toxin type A Protein / enzyme biologic 5 iu

Indications

No indication recorded.